Navigate
X
    QualityStocks
  • 17 years ago

ViroPharma Incorporated (NASDAQ: VPHM)

ViroPharma Incorporated (NASDAQ: VPHM), a multinational biotechnology company, is focused on developing and commercializing innovative products that target unmet medical needs. The company is currently dedicating their efforts to developing these products for physician specialists that support patients with serious diseases caused by CMV, C. difficile, and hereditary angioedema. Maribavir, VioPharma’s lead clinical compound, is an orally-administered antiviral Phase 3 drug designed to prevent cytomegalovirus (CMV) disease in transplant patients. For further information, visit the Company’s web site at www.viropharma.com.

Tags Rodman & Renshaw
Related Post
  1. New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Looks Forward to Bolivia Presidential Runoff, Hoping for Increased Foreign Investment Support

    Bolivia heads into an October presidential runoff, signaling a possible shift toward more pro-business policies,…

  2. Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF): Building Value Through Nevada’s Walker Lane

    Four-property portfolio in Nevada’s Walker Lane anchored by the Santa Fe Mine project with over…

  3. ONAR Holding Corp. (ONAR) Powers Smarter Marketing with Agency Innovation

    As budgets tighten and demands intensify, CMOs are questioning traditional marketing models ONAR is seizing…